{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:28:15Z","timestamp":1793978895750,"version":"4.8.0"},"reference-count":260,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018936","name":"Qingdao Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018936","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neubiorev.2026.106840","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:17:43Z","timestamp":1782919063000},"page":"106840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Peripheral nervous system involvement in Parkinson\u2019s disease: Peripheral neuropathy, neuromuscular junction dysfunction, and clinical implications"],"prefix":"10.1016","volume":"188","author":[{"given":"Junliang","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2026.106840_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.neubiorev.2026.106840_bib2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/mds.20113","article-title":"Does parkin play a role in the peripheral nervous system? A family report","volume":"19","author":"Abbruzzese","year":"2004","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.neubiorev.2026.106840_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2021.102835","article-title":"Vagus nerve ultrasonography in Parkinson's disease: A systematic review and meta-analysis","volume":"234","author":"Abdelnaby","year":"2021","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/cells8080776","article-title":"Rifampicin and its derivative rifampicin quinone reduce microglial inflammatory responses and neurodegeneration induced in vitro by \u03b1-synuclein fibrillary aggregates","volume":"8","author":"Acu\u00f1a","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neubiorev.2026.106840_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1212\/WNL.0000000000000641","article-title":"Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study","volume":"83","author":"Adler","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106840_bib6","first-page":"1","article-title":"Role of alpha-synuclein in inducing innate and adaptive immunity in Parkinson disease","volume":"5","author":"Allen Reish","year":"2015","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.neubiorev.2026.106840_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0361-9230(00)00230-6","article-title":"The blood\u2013nerve barrier: enzymes, transporters and receptors\u2014a comparison with the blood\u2013brain barrier","volume":"52","author":"Allt","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2026.106840_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/cells9010197","article-title":"Mitochondrial mechanisms of neuromuscular junction degeneration with aging","volume":"9","author":"Anagnostou","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neubiorev.2026.106840_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-5347(17)58685-1","article-title":"Cystometric, sphincter and electromyelographic abnormalities in Parkinson\u2019s disease","volume":"116","author":"Andersen","year":"1976","journal-title":"J. Urol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archneur.1971.00480310078007","article-title":"Autonomic deficits in Parkinson's syndrome","volume":"24","author":"Appenzeller","year":"1971","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib11","first-page":"185","article-title":"Expression of synaptophysin protein in different dopaminergic cell lines","volume":"2","author":"Bai","year":"2014","journal-title":"J. Biochem. Pharmacol. Res."},{"key":"10.1016\/j.neubiorev.2026.106840_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(71)90893-2","article-title":"Degeneration of the autonomic nervous system","volume":"298","author":"Bannister","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2026.106840_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/j.1460-2075.1982.tb01207.x","article-title":"Purification of a new neurotrophic factor from mammalian brain","volume":"1","author":"Barde","year":"1982","journal-title":"EMBO J."},{"key":"10.1016\/j.neubiorev.2026.106840_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.07.056","article-title":"Clinical approach to nonmotor sensory fluctuations in Parkinson's disease","volume":"310","author":"Bayulkem","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nrneurol.2014.88","article-title":"The clinical approach to autonomic failure in neurological disorders","volume":"10","author":"Benarroch","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/jnc.15516","article-title":"The role of neuroimaging in Parkinson\u2019s disease","volume":"159","author":"Bidesi","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2026.106840_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neulet.2013.02.047","article-title":"Chronic exposure to rotenone, a dopaminergic toxin, results in peripheral neuropathy associated with dopaminergic damage","volume":"541","author":"Binienda","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2026.106840_bib18","series-title":"Peripheral nerve injuries: a clinical guide","first-page":"1","article-title":"The peripheral nervous system: anatomy and function","author":"Birch","year":"2012"},{"key":"10.1016\/j.neubiorev.2026.106840_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2020.03.018","article-title":"SLC25A46 mutations in patients with Parkinson's Disease and optic atrophy","volume":"74","author":"Bitetto","year":"2020","journal-title":"Park. & Relat. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1474-4422(21)00377-X","article-title":"Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches","volume":"21","author":"Bohnen","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nchembio782","article-title":"Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate \u03b1-synuclein fibrilization","volume":"2","author":"Bosco","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2026.106840_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/jnnp.41.8.709","article-title":"Evidence for a change in neurotransmitter affecting oesophageal motility in Parkinson's disease","volume":"41","author":"Bramble","year":"1978","journal-title":"J. Neurol. Neurosurg. & Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106840_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnins.2018.00080","article-title":"Mechanisms of alpha-Synuclein Induced Synaptopathy in Parkinson's Disease","volume":"12","author":"Bridi","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/mds.24054","article-title":"Prevalence of pain in Parkinson's disease: a systematic review using the modified QUADAS tool","volume":"27","author":"Broen","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jnnp.45.4.372","article-title":"Familial extrapyramidal disease with peripheral neuropathy","volume":"45","author":"Byrne","year":"1982","journal-title":"J. Neurol. Neurosurg. & Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106840_bib28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell. death & Dis."},{"key":"10.1016\/j.neubiorev.2026.106840_bib29","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/brain\/awad150","article-title":"Advances in understanding the function of alpha-synuclein: implications for Parkinson\u2019s disease","volume":"146","author":"Calabresi","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2026.106840_bib30","first-page":"732","article-title":"Peripheral Neuropathy: Evaluation and Differential Diagnosis","volume":"102","author":"Castelli","year":"2020","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.neubiorev.2026.106840_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/B978-0-444-52902-2.00003-5","article-title":"Gross anatomy and development of the peripheral nervous system","volume":"115","author":"Catala","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib32","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.25585","article-title":"Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study","volume":"28","author":"Ceravolo","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.nbd.2011.10.014","article-title":"Pathological correlates of gastrointestinal dysfunction in Parkinson's disease","volume":"46","author":"Cersosimo","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2026.106840_bib34","doi-asserted-by":"crossref","unstructured":"Chakraborty CJCdt (2007), Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing. 8:469-482.","DOI":"10.2174\/138945007780058988"},{"key":"10.1016\/j.neubiorev.2026.106840_bib35","first-page":"597","article-title":"The role of oxidative stress in","volume":"9","author":"Chang","year":"2020","journal-title":"Park. \u2019S. Dis."},{"key":"10.1016\/j.neubiorev.2026.106840_bib36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/biom12050655","article-title":"Extracellular alpha-synuclein: mechanisms for glial cell internalization and activation","volume":"12","author":"Chavarr\u00eda","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.neubiorev.2026.106840_bib37","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1093\/brain\/awaf051","article-title":"Parkinson's disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss","volume":"148","author":"Chemla","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2026.106840_bib38","unstructured":"Chen A., Yangzom T., Sullivan G.J., Liang K.X.Jb (2023), Mitochondrial Dysfunction and Neuronal Anomalies in POLG Mutant Midbrain Organoids.2023.2009. 2027.559684."},{"key":"10.1016\/j.neubiorev.2026.106840_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104700","article-title":"Autonomic dysfunction in Parkinson\u2019s disease: Implications for pathophysiology, diagnosis, and treatment","volume":"134","author":"Chen","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2026.106840_bib40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jchemneu.2010.12.001","article-title":"The role of alpha-synuclein in neurotransmission and synaptic plasticity","volume":"42","author":"Cheng","year":"2011","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neubiorev.2026.106840_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12974-023-02720-1","article-title":"alpha-Synuclein induces prodromal symptoms of Parkinson's disease via activating TLR2\/MyD88\/NF-kappaB pathway in Schwann cells of vagus nerve in a rat model","volume":"20","author":"Cheng","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neubiorev.2026.106840_bib42","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","article-title":"Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration","volume":"11","author":"Choi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2026.106840_bib43","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/stmcls\/sxae042","article-title":"Advancing Parkinson\u2019s disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells","volume":"42","author":"Clark","year":"2024","journal-title":"Stem Cells"},{"key":"10.1016\/j.neubiorev.2026.106840_bib44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00018-024-05262-8","article-title":"PRKN-linked familial Parkinson\u2019s disease: cellular and molecular mechanisms of disease-linked variants","volume":"81","author":"Clausen","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2026.106840_bib46","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.parkreldis.2014.10.010","article-title":"Peripheral nervous system involvement in Parkinson's disease: evidence and controversies","volume":"20","author":"Comi","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/brain\/awac026","article-title":"Peripheral neuropathy in Parkinson's disease: prevalence and functional impact on gait and balance","volume":"146","author":"Corra","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2026.106840_bib48","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.4103\/0028-3886.359257","article-title":"Neuropathic pain in Parkinson's disease","volume":"70","author":"Cortes-Altamirano","year":"2022","journal-title":"Neurol. India"},{"key":"10.1016\/j.neubiorev.2026.106840_bib49","doi-asserted-by":"crossref","first-page":"a009431","DOI":"10.1101\/cshperspect.a009431","article-title":"Parkinson\u2019s disease: gene therapies","volume":"2","author":"Coune","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neubiorev.2026.106840_bib50","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0896-6273(95)90267-8","article-title":"Differential role of the low affinity neurotrophin receptor (p75) in retrograde axonal transport of the neurotrophins","volume":"14","author":"Curtis","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2026.106840_bib51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40120-019-00152-9","article-title":"Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer","volume":"8","author":"Cutsforth-Gregory","year":"2019","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.neubiorev.2026.106840_bib52","article-title":"A Comprehensive Review of the Role of Biomarkers in Early Diagnosis of Parkinson's Disease","volume":"16","author":"Das","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.neubiorev.2026.106840_bib53","first-page":"859","article-title":"Early-onset familial parkinsonism due to POLG mutations","volume":"59","author":"Davidzon","year":"2006","journal-title":"SJAoNOJotANA Soc. tCN"},{"key":"10.1016\/j.neubiorev.2026.106840_bib54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12883-016-0667-3","article-title":"Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism","volume":"16","author":"de Araujo","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib55","first-page":"569","article-title":"The VPS35 gene and Parkinson's disease","volume":"28","author":"Deng","year":"2013"},{"key":"10.1016\/j.neubiorev.2026.106840_bib56","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/1097-4598(200010)23:10<1576::AID-MUS15>3.0.CO;2-J","article-title":"Effects of resistance training on neuromuscular junction morphology","volume":"23","author":"Deschenes","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neubiorev.2026.106840_bib57","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1586\/ern.09.117","article-title":"Current strategies in the treatment of Parkinson\u2019s disease and a personalized approach to management","volume":"9","author":"Diaz","year":"2009","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.neubiorev.2026.106840_bib58","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.3390\/ijms23094610","article-title":"Molecular biomarkers and their implications for the early diagnosis of selected neurodegenerative diseases","volume":"23","author":"Doroszkiewicz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib59","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4103\/1673-5374.300980","article-title":"Oxidative stress factors in Parkinson\u2019s disease","volume":"16","author":"Dorszewska","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neubiorev.2026.106840_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations","volume":"10","author":"Dresser","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neubiorev.2026.106840_bib61","first-page":"248","article-title":"Electromyography: Recording electrical signals from human muscle","volume":"21","author":"Drewes","year":"2000","journal-title":"Test. Stud. Lab. Teach. Assoc. Biol. Lab. Educ. (ABLE)"},{"key":"10.1016\/j.neubiorev.2026.106840_bib62","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3390\/cells8111359","article-title":"Peripheral delivery of neural precursor cells ameliorates parkinson\u2019s disease-associated pathology","volume":"8","author":"Edwards","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neubiorev.2026.106840_bib63","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnins.2018.00612","article-title":"Parkinson\u2019s disease: biomarkers, treatment, and risk factors","volume":"12","author":"Emamzadeh","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib64","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.expneurol.2007.02.008","article-title":"Non-steroidal anti-inflammatory drugs in Parkinson's disease","volume":"205","author":"Esposito","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70174-z","article-title":"Differential protein expression in diverse brain areas of Parkinson\u2019s and Alzheimer\u2019s disease patients","volume":"10","author":"Esteves","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2026.106840_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/35065004","article-title":"Synaptotagmin I functions as a calcium regulator of release probability","volume":"410","author":"Fern\u00e1ndez-Chac\u00f3n","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2026.106840_bib67","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2021\/e2675","article-title":"Parkinson-related neuropathy","volume":"76","author":"Finsterer","year":"2021","journal-title":"Clin. (Sao Paulo)"},{"key":"10.1016\/j.neubiorev.2026.106840_bib68","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(13)61914-5","article-title":"Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin\/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial","volume":"383","author":"Fitzgerald","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2026.106840_bib69","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/mds.22716","article-title":"Pain in Parkinson's disease","volume":"25","author":"Ford","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib70","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1124\/jpet.115.228510","article-title":"Enteric Dysfunctions in Experimental Parkinson's Disease: Alterations of Excitatory Cholinergic Neurotransmission Regulating Colonic Motility in Rats","volume":"356","author":"Fornai","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2026.106840_bib71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40478-023-01711-w","article-title":"Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"12","author":"Frigerio","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neubiorev.2026.106840_bib72","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/brain\/awae336","article-title":"MBNL deficiency in motor neurons disrupts neuromuscular junction maintenance and gait coordination","volume":"148","author":"Frison-Roche","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2026.106840_bib73","first-page":"1189","article-title":"Plant-derived neuroprotective agents in Parkinson\u2019s disease","volume":"7","author":"Fu","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.neubiorev.2026.106840_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autneu.2006.05.003","article-title":"The organisation of the autonomic nervous system: peripheral connections","volume":"130","author":"Furness","year":"2006","journal-title":"Autonomic Neuroscience Basic Clinical"},{"key":"10.1016\/j.neubiorev.2026.106840_bib75","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/brain\/awl114","article-title":"PINK1 protein in normal human brain and Parkinson's disease","volume":"129","author":"Gandhi","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2026.106840_bib76","first-page":"1","article-title":"GBA-associated Parkinson\u2019s disease and other synucleinopathies","volume":"18","author":"Gan-Or","year":"2018","journal-title":"RNJCn Rep. N."},{"key":"10.1016\/j.neubiorev.2026.106840_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/mus.70243","article-title":"Is Levodopa Fueling Peripheral Nerve Damage? A Clinical and Neurophysiological Insight Into Polyneuropathy in Parkinson's Disease","author":"Garasto","year":"2026","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neubiorev.2026.106840_bib78","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/02692163231214408","article-title":"A systematic practice review: Providing palliative care for people with Parkinson\u2019s disease and their caregivers","volume":"38","author":"Garon","year":"2024","journal-title":"Palliat. Med."},{"key":"10.1016\/j.neubiorev.2026.106840_bib79","article-title":"\u03b1-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity","volume":"119","author":"Ghanem","year":"2022"},{"key":"10.1016\/j.neubiorev.2026.106840_bib80","unstructured":"Gibbons C.H., Levine T., Adler C., Bellaire B., Wang N., Stohl J., Agarwal P., Aldridge G.M., et al. (2024), Skin biopsy detection of phosphorylated \u03b1-synuclein in patients with synucleinopathies."},{"key":"10.1016\/j.neubiorev.2026.106840_bib81","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s40478-014-0176-9","article-title":"Models of \u03b1-synuclein aggregation in Parkinson\u2019s disease","volume":"2","author":"Gir\u00e1ldez-P\u00e9rez","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neubiorev.2026.106840_bib82","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.HYP.0000188052.69549.e4","article-title":"Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment","volume":"46","author":"Goldstein","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.neubiorev.2026.106840_bib83","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10286-007-0396-1","article-title":"Cardiac sympathetic denervation preceding motor signs in Parkinson disease","volume":"17","author":"Goldstein","year":"2007","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.neubiorev.2026.106840_bib84","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling Parkinson's Disease With the Alpha-Synuclein Protein","volume":"11","author":"Gomez-Benito","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib85","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1532-5415.1981.tb02188.x","article-title":"Perhexiline maleate as a cause of reversible parkinsonism and peripheral neuropathy","volume":"29","author":"Gordon","year":"1981","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.neubiorev.2026.106840_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14020630","article-title":"Neurogenic Orthostatic Hypotension in Parkinson Disease-A Narrative Review of Diagnosis and Management","volume":"14","author":"Grosu","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neubiorev.2026.106840_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.580311","article-title":"Parkinson\u2019s disease: Can targeting inflammation be an effective neuroprotective strategy?","volume":"14","author":"Gundersen","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2025.01.053","article-title":"Skeletal muscle innervation: Reactive oxygen species as regulators of neuromuscular junction dynamics and motor unit remodeling","author":"Guzman","year":"2025","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.neubiorev.2026.106840_bib89","first-page":"305","article-title":"Recent advances in biomarkers for Parkinson\u2019s disease","volume":"10","author":"He","year":"2018","journal-title":"QJFian"},{"key":"10.1016\/j.neubiorev.2026.106840_bib90","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease\u2013a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2026.106840_bib91","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1523\/JNEUROSCI.23-02-00561.2003","article-title":"Glial cell line-derived neurotrophic factor alters axon schwann cell units and promotes myelination in unmyelinated nerve fibers","volume":"23","author":"Hoke","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106101","article-title":"Brain-first vs. body-first Parkinson's disease: An update on recent evidence","volume":"122","author":"Horsager","year":"2024","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib93","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s12035-018-1151-4","article-title":"Peripheral biomarkers for early detection of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"56","author":"Htike","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib94","doi-asserted-by":"crossref","first-page":"10808","DOI":"10.3390\/ijms231810808","article-title":"Impact of environmental risk factors on mitochondrial dysfunction, neuroinflammation, protein misfolding, and oxidative stress in the etiopathogenesis of Parkinson\u2019s disease","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib95","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. & Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106840_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003640","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency","volume":"4","author":"Hwu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neubiorev.2026.106840_bib97","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jns.2011.07.014","article-title":"Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences","volume":"310","author":"Iodice","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib98","doi-asserted-by":"crossref","first-page":"8058","DOI":"10.3390\/ijms22158058","article-title":"The neuromuscular junction: roles in aging and neuromuscular disease","volume":"22","author":"Iyer","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib99","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nbd.2011.10.025","article-title":"Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis","volume":"46","author":"Jain","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2026.106840_bib100","first-page":"8338","article-title":"The prion-like spreading of alpha-synuclein in Parkinson\u2019s disease: update on models and hypotheses","volume":"22","author":"Jan","year":"2021"},{"key":"10.1016\/j.neubiorev.2026.106840_bib101","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. & Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106840_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000130","article-title":"Dopamine gene therapy for Parkinson\u2019s disease in a nonhuman primate without associated dyskinesia","volume":"1","author":"Jarraya","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neubiorev.2026.106840_bib103","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ana.26291","article-title":"Aerobic exercise alters brain function and structure in Parkinson's disease: a randomized controlled trial","volume":"91","author":"Johansson","year":"2022","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106840_bib104","doi-asserted-by":"crossref","first-page":"I28","DOI":"10.1007\/s00415-003-1105-z","article-title":"Autonomic dysfunctions in idiopathic Parkinson's disease","volume":"250","author":"Jost","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2009.08.020","article-title":"Gastrointestinal dysfunction in Parkinson's Disease","volume":"289","author":"Jost","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib106","first-page":"235","article-title":"Comparative study of adeno-associated virus, adenovirus, bacu lovirus and lentivirus vectors for gene therapy of the eyes","volume":"17","author":"Kalesnykas","year":"2017"},{"key":"10.1016\/j.neubiorev.2026.106840_bib107","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12031-022-01970-7","article-title":"Evaluation of Sarcopenia Using Biomarkers of the Neuromuscular Junction in Parkinson's Disease","volume":"72","author":"Karim","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib108","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal Propagation of Pathologic alpha-Synuclein from the Gut to the Brain Models Parkinson's Disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2026.106840_bib109","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/brain\/awv132","article-title":"Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction","volume":"138","author":"Kinghorn","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2026.106840_bib110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","article-title":"Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors","volume":"11","author":"Klingelhoefer","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib111","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jamaneurol.2019.4992","article-title":"Comparison of integrated outpatient palliative care with standard care in patients with Parkinson disease and related disorders: a randomized clinical trial","volume":"77","author":"Kluger","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib112","article-title":"Cardiovascular autonomic failure correlates with cutaneous autonomic denervation in PD and MSA","author":"Koay","year":"2025","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.neubiorev.2026.106840_bib113","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/bs.irn.2017.01.009","article-title":"Genetics of Parkinson's Disease: Genotype-Phenotype Correlations","volume":"132","author":"Koros","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib114","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3390\/genes14112097","article-title":"The landscape of monogenic Parkinson\u2019s disease in populations of non-European ancestry: a narrative review","volume":"14","author":"Koros","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.neubiorev.2026.106840_bib115","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1021\/acschemneuro.2c00730","article-title":"Comprehensive Review on Potential Signaling Pathways Involving the Transfer of alpha-Synuclein from the Gut to the Brain That Leads to Parkinson's Disease","volume":"14","author":"Kumari","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib116","series-title":"Investigation Into the Pathogenic Mechanisms of the SLC25A46-Related Mitochondriopathy in the Mouse Model","author":"Kusurkar","year":"2023"},{"key":"10.1016\/j.neubiorev.2026.106840_bib117","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s42466-024-00354-z","article-title":"Large-fiber neuropathy in Parkinson's disease: a narrative review","volume":"6","author":"Kwon","year":"2024","journal-title":"Neurol. Res. Pract."},{"key":"10.1016\/j.neubiorev.2026.106840_bib118","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1468-1331.2006.01512.x","article-title":"EFNS guidelines on the diagnosis and management of orthostatic hypotension","volume":"13","author":"Lahrmann","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib119","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3349\/ymj.2020.61.12.1050","article-title":"Peripheral Neuropathy in de novo Patients with Parkinson's Disease","volume":"61","author":"Lee","year":"2020","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.neubiorev.2026.106840_bib120","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1042\/BST20120113","article-title":"The synaptic function of LRRK2","volume":"40","author":"Lee","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neubiorev.2026.106840_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2024.105235","article-title":"Mitochondrial disorders are associated with morphological neuromuscular junction defects","volume":"45","author":"Lessard","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib122","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.3306916","article-title":"The nerve growth factor 35 years later","volume":"237","author":"Levi-Montalcini","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2026.106840_bib123","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(11)70039-4","article-title":"AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial","volume":"10","author":"LeWitt","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.756538","article-title":"Musculoskeletal pain in Parkinson's disease","volume":"12","author":"Li","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-physiol-022516-034255","article-title":"Neuromuscular junction formation, aging, and disorders","volume":"80","author":"Li","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib126","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jshs.2018.09.010","article-title":"The contribution of small and large sensory afferents to postural control in patients with peripheral neuropathy","volume":"8","author":"Li","year":"2019","journal-title":"J. Sport. Health Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib127","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40035-025-00531-3","article-title":"Microglia in the crosstalk between peripheral and central nervous systems in Parkinson's disease","volume":"14","author":"Li","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neubiorev.2026.106840_bib128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41420-024-01824-8","article-title":"Phosphorylated \u03b1-synuclein deposited in Schwann cells interacting with TLR2 mediates cell damage and induces Parkinson\u2019s disease autonomic dysfunction","volume":"10","author":"Li","year":"2024","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.neubiorev.2026.106840_bib129","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1093\/hmg\/ddx262","article-title":"Loss of SLC25A46 causes neurodegeneration by affecting mitochondrial dynamics and energy production in mice","volume":"26","author":"Li","year":"2017","journal-title":"Human. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2026.106840_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2025.138569","article-title":"Biomass fuel induces neuroinflammation and neurodegeneration via the astrocyte-microglia IL-17A\/IL-17RA pathway","volume":"494","author":"Liang","year":"2025","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.neubiorev.2026.106840_bib131","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1021\/acsnano.4c13914","article-title":"Polystyrene Nanoplastics Hitch-Hike the Gut-Brain Axis to Exacerbate Parkinson's Pathology","volume":"19","author":"Liang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.neubiorev.2026.106840_bib132","doi-asserted-by":"crossref","unstructured":"Lill C.M.J.M., probes c (2016), Genetics of Parkinson's disease. 30:386-396.","DOI":"10.1016\/j.mcp.2016.11.001"},{"key":"10.1016\/j.neubiorev.2026.106840_bib133","article-title":"Unraveling Parkinson's disease: The mystery of mitochondria and the role of aging","volume":"13","author":"Liu","year":"2026","journal-title":"Genes. Dis."},{"key":"10.1016\/j.neubiorev.2026.106840_bib134","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1093\/brain\/awac225","article-title":"Vitamins B6 and B12, levodopa, and their complex interactions in patients with Parkinson\u2019s disease","volume":"145","author":"Liz\u00e1rraga","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2026.106840_bib135","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1185\/03007995.2015.1087988","article-title":"Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions","volume":"31","author":"Loavenbruck","year":"2015","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.neubiorev.2026.106840_bib136","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.11124\/JBISRIR-D-18-00005","article-title":"Effectiveness of non-pharmacological interventions to treat orthostatic hypotension in elderly people and people with a neurological condition: a systematic review","volume":"18","author":"Logan","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"10.1016\/j.neubiorev.2026.106840_bib137","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.10613","article-title":"How much phenotypic variation can be attributed to parkin genotype?","volume":"54","author":"Lohmann","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib138","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.actbio.2016.08.006","article-title":"Electrical stimulation enhances the acetylcholine receptors available for neuromuscular junction formation","volume":"45","author":"Lozano","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.neubiorev.2026.106840_bib139","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40265-014-0343-0","article-title":"Catechol-O-methyltransferase inhibitors in Parkinson\u2019s disease","volume":"75","author":"M\u00fcller","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.neubiorev.2026.106840_bib140","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00702-023-02666-x","article-title":"The vicious circle between homocysteine, methyl group-donating vitamins and chronic levodopa intake in Parkinson\u2019s disease","volume":"131","author":"M\u00fcller","year":"2024","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2026.106840_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.598457","article-title":"Role of the peripheral nervous system in PD pathology, diagnosis, and treatment","volume":"15","author":"Ma","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib142","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1021\/acschemneuro.8b00383","article-title":"Alpha-synuclein in peripheral tissues in Parkinson\u2019s disease","volume":"10","author":"Ma","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib143","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature00846","article-title":"The C2B Ca2+-binding motif of synaptotagmin is required for synaptic transmission in vivo","volume":"418","author":"Mackler","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2026.106840_bib144","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s43587-025-00851-z","article-title":"Pre-symptomatic Parkinson's disease blood test quantifying repetitive sequence motifs in transfer RNA fragments","volume":"5","author":"Madrer","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.neubiorev.2026.106840_bib145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","article-title":"Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson\u2019s disease and other synucleinopathies","volume":"8","author":"Magalh\u00e3es","year":"2022","journal-title":"npj Park. 's. Dis."},{"key":"10.1016\/j.neubiorev.2026.106840_bib146","first-page":"1","article-title":"Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments","volume":"6","author":"Maiti","year":"2017"},{"key":"10.1016\/j.neubiorev.2026.106840_bib147","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/mt.2009.286","article-title":"Comparative transduction efficiency of AAV vector serotypes 1\u20136 in the substantia nigra and striatum of the primate brain","volume":"18","author":"Markakis","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neubiorev.2026.106840_bib148","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jama.2025.19400","article-title":"Peripheral neuropathy: a review","volume":"335","author":"Mauermann","year":"2026","journal-title":"Jama"},{"key":"10.1016\/j.neubiorev.2026.106840_bib149","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/brain\/awac087","article-title":"Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism","volume":"145","author":"Merino-Gal\u00e1n","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2026.106840_bib150","doi-asserted-by":"crossref","first-page":"s32","DOI":"10.1007\/s100720300035","article-title":"Autonomic dysfunction in Parkinson's disease","volume":"24","author":"Micieli","year":"2003","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib151","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s43587-025-00870-w","article-title":"Recycling tRNA fragment 'trash' into treasure","volume":"5","author":"Middleton","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.neubiorev.2026.106840_bib152","first-page":"2307","article-title":"Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease","volume":"79","author":"Milber","year":"2012"},{"key":"10.1016\/j.neubiorev.2026.106840_bib153","first-page":"S40","article-title":"Biomarkers of Parkinson\u2019s disease: present and future","volume":"64","author":"Miller","year":"2015"},{"key":"10.1016\/j.neubiorev.2026.106840_bib154","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/ph16070908","article-title":"A review on natural antioxidants for their role in the treatment of Parkinson\u2019s disease","volume":"16","author":"Mittal","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neubiorev.2026.106840_bib155","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.parkreldis.2013.02.006","article-title":"Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery","volume":"19","author":"Muller","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib156","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/mds.28922","article-title":"Air pollution and the risk of Parkinson's disease: a review","volume":"37","author":"Murata","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib157","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3390\/biom12091199","article-title":"The effect of aggregated alpha synuclein on synaptic and axonal proteins in Parkinson\u2019s disease\u2014a systematic review","volume":"12","author":"Murphy","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.neubiorev.2026.106840_bib158","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1017\/S0954422419000106","article-title":"The role of one-carbon metabolism and homocysteine in Parkinson\u2019s disease onset, pathology and mechanisms","volume":"32","author":"Murray","year":"2019","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.neubiorev.2026.106840_bib159","article-title":"The peripheral nervous system","volume":"150","author":"Murtazina","year":"2023"},{"key":"10.1016\/j.neubiorev.2026.106840_bib160","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70059","article-title":"Altered Mitochondrial Bioenergetics and Calcium Kinetics in Young-Onset PLA2G6 Parkinson's Disease iPSCs","volume":"169","author":"Musthafa","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2026.106840_bib161","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11910-012-0323-2","article-title":"Uses of skin biopsy for sensory and autonomic nerve assessment","volume":"13","author":"Myers","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neubiorev.2026.106840_bib162","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/jnr.21191","article-title":"Oxidative damage in nucleic acids and Parkinson's disease","volume":"85","author":"Nakabeppu","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2026.106840_bib163","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/jnnp.57.12.1525","article-title":"Chronic idiopathic axonal polyneuropathy: a five year follow up","volume":"57","author":"Notermans","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106840_bib164","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ncl.2021.06.002","article-title":"Nerve conduction studies: basic concepts and patterns of abnormalities","volume":"39","author":"O\u2019Bryan","year":"2021","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.neubiorev.2026.106840_bib165","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2174\/1389202914666131210205839","article-title":"Mutations in PRKN and SNCA genes important for the progress of Parkinson\u2019s disease","volume":"14","author":"Oczkowska","year":"2013","journal-title":"Curr. Genom."},{"key":"10.1016\/j.neubiorev.2026.106840_bib166","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jnc.13750","article-title":"Current and experimental treatments of Parkinson disease: A guide for neuroscientists","volume":"139","author":"Oertel","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2026.106840_bib167","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/14728222.2017.1369960","article-title":"Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders","volume":"21","author":"Ohno","year":"2017","journal-title":"Expert. Opin. Ther. Targets"},{"key":"10.1016\/j.neubiorev.2026.106840_bib168","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1353-8020(02)00114-1","article-title":"Sensory neuropathy in autosomal recessive juvenile parkinsonism (PARK2)","volume":"9","author":"Okuma","year":"2003","journal-title":"Park. & Relat. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib169","doi-asserted-by":"crossref","unstructured":"Pagano G., Niccolini F., Fusar-Poli P., Politis M.J.Aon (2017), Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies. 81:171-180.","DOI":"10.1002\/ana.24859"},{"key":"10.1016\/j.neubiorev.2026.106840_bib170","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib171","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12984-021-00811-9","article-title":"Peripheral electrical stimulation to reduce pathological tremor: a review","volume":"18","author":"Pascual-Valdunciel","year":"2021","journal-title":"J. Neuroeng. Rehabil."},{"key":"10.1016\/j.neubiorev.2026.106840_bib172","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.690632","article-title":"A pH-eQTL Interaction at the RIT2\u2013SYT4 Parkinson\u2019s Disease Risk Locus in the Substantia Nigra","volume":"13","author":"Patel","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib173","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1007\/s10072-020-04407-4","article-title":"Peripheral neuropathy in Parkinson's disease","volume":"41","author":"Paul","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib174","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/brain\/awad364","article-title":"Multimodal assessment of mitochondrial function in Parkinson's disease","volume":"147","author":"Payne","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2026.106840_bib175","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3389\/fneur.2018.00951","article-title":"Axonal Degeneration of the Vagus Nerve in Parkinson's Disease-A High-Resolution Ultrasound Study","volume":"9","author":"Pelz","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib176","article-title":"Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease","volume":"2","author":"Perez-Lloret","year":"2016","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.neubiorev.2026.106840_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2020.07.003","article-title":"The role of RHOT1 and RHOT2 genetic variation on Parkinson disease risk and onset","volume":"97","author":"Peri\u00f1\u00e1n","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2026.106840_bib178","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1046\/j.1523-1755.63.s84.33.x","article-title":"Possible mechanisms of homocysteine toxicity","volume":"63","author":"Perna","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.neubiorev.2026.106840_bib179","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s13311-020-00897-4","article-title":"Autonomic Dysfunction in Parkinson's Disease","volume":"17","author":"Pfeiffer","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neubiorev.2026.106840_bib180","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.27390","article-title":"Low-fat versus ketogenic diet in Parkinson's disease: a pilot randomized controlled trial","volume":"33","author":"Phillips","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib181","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2026.106840_bib182","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2006.09.008","article-title":"Falls in patients with neuromuscular disorders","volume":"251","author":"Pieterse","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib183","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.25274","article-title":"A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease","volume":"84","author":"Pihlstr\u00f8m","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib184","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1555175","article-title":"Key motor and non-motor features in early dementia with Lewy bodies","volume":"16","author":"Planas-Ballv\u00e9","year":"2025","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib185","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3390\/biom10060912","article-title":"The future of targeted gene-based treatment strategies and biomarkers in Parkinson\u2019s disease","volume":"10","author":"Polissidis","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.neubiorev.2026.106840_bib186","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib187","first-page":"1007","article-title":"Behavioral tests in neurotoxin-induced animal models of Parkinson\u2019s disease","volume":"9","author":"Prasad","year":"2020"},{"key":"10.1016\/j.neubiorev.2026.106840_bib188","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archneur.1985.04060070089022","article-title":"Radial compression neuropathy in advanced Parkinson's disease","volume":"42","author":"Preston","year":"1985","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib189","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/brain\/awac191","article-title":"Early bioenergetic and autophagy impairments at the Parkinson\u2019s disease synapse","volume":"145","author":"Prieto","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2026.106840_bib190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2008.02057.x","article-title":"New insights into the pathology of Parkinson\u2019s disease: does the peripheral autonomic system become central?","volume":"15","author":"Probst","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib191","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1177\/1545968320952799","article-title":"Physiotherapy in Parkinson\u2019s disease: a meta-analysis of present treatment modalities","volume":"34","author":"Radder","year":"2020","journal-title":"Neurorehabilitation Neural Repair."},{"key":"10.1016\/j.neubiorev.2026.106840_bib192","series-title":"Accuracy of Parkinson disease diagnosis unchanged in 2 decades","first-page":"386","author":"Rajput","year":"2014"},{"key":"10.1016\/j.neubiorev.2026.106840_bib193","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/medicina57050457","article-title":"Sensory-motor mechanisms increasing falls risk in diabetic peripheral neuropathy","volume":"57","author":"Reeves","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.neubiorev.2026.106840_bib194","first-page":"17","article-title":"Inflammation kinase PKR phosphorylates \u03b1-synuclein and causes \u03b1-synuclein-dependent cell death","volume":"115","author":"Reimer","year":"2018"},{"key":"10.1016\/j.neubiorev.2026.106840_bib195","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1172\/JCI45794","article-title":"Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease","volume":"121","author":"Rhee","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neubiorev.2026.106840_bib196","doi-asserted-by":"crossref","unstructured":"Robert C., Wilson C., Lipton R., Arreto C.-D.J.P., Disorders R. (2019), Parkinson's disease: evolution of the scientific literature from 1983 to 2017 by countries and journals. 61:10-18.","DOI":"10.1016\/j.parkreldis.2018.11.011"},{"key":"10.1016\/j.neubiorev.2026.106840_bib197","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature00915","article-title":"Synaptotagmins I and IV promote transmitter release independently of Ca2+ binding in the C2A domain","volume":"418","author":"Robinson","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2026.106840_bib198","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.610964","article-title":"The neuromuscular junction in health and disease: molecular mechanisms governing synaptic formation and homeostasis","volume":"13","author":"Rodr\u00edguez Cruz","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib199","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mdc3.12688","article-title":"Levodopa-induced neuropathy: a systematic review","volume":"6","author":"Romagnolo","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.neubiorev.2026.106840_bib200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13024-016-0140-1","article-title":"LRRK2 at the interface of autophagosomes, endosomes and lysosomes","volume":"11","author":"Roosen","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2026.106840_bib201","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/brain\/awaa401","article-title":"Targeted sequencing of Parkinson\u2019s disease loci genes highlights SYT11, FGF20 and other associations","volume":"144","author":"Rudakou","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2026.106840_bib202","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.conb.2013.09.008","article-title":"The role of myelin and oligodendrocytes in axonal energy metabolism","volume":"23","author":"Saab","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib203","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/15548627.2019.1586260","article-title":"Mitochondrial transport proteins RHOT1 and RHOT2 serve as docking sites for PRKN-mediated mitophagy","volume":"15","author":"Safiulina","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.neubiorev.2026.106840_bib204","doi-asserted-by":"crossref","DOI":"10.5114\/aoms\/131629","article-title":"mRNA expression profiling of mitochondrial subunits in subjects with Parkinson\u2019s disease","author":"Salemi","year":"2021","journal-title":"Archives medical science AMS 19678"},{"key":"10.1016\/j.neubiorev.2026.106840_bib205","first-page":"199","article-title":"The Role of VPS35 in the Pathobiology of Parkinson\u2019s Disease","volume":"41","author":"Sassone","year":"2021"},{"key":"10.1016\/j.neubiorev.2026.106840_bib206","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/jcbfm.2013.128","article-title":"Why does brain metabolism not favor burning of fatty acids to provide energy?-Reflections on disadvantages of the use of free fatty acids as fuel for brain","volume":"33","author":"Sch\u00f6nfeld","year":"2013","journal-title":"J. Cereb. Blood Flow. & Metab."},{"key":"10.1016\/j.neubiorev.2026.106840_bib207","doi-asserted-by":"crossref","unstructured":"Schaeffer E., Kluge A., Schulte C., Deuschle C., Bunk J., Welzel J., Maetzler W., Berg D.J.Jo.PsD. (2024), Association of Misfolded \u03b1-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson\u2019s Disease Diagnosis and Duration.1-13.","DOI":"10.3233\/JPD-230390"},{"key":"10.1016\/j.neubiorev.2026.106840_bib208","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib209","article-title":"Assessment of SLC25A46 variants in idiopathic Parkinson\u2019s disease","author":"Schneider","year":"2025","journal-title":"Park. & Relat. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib210","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.neuron.2011.06.003","article-title":"Mitochondria: the next (neurode) generation","volume":"70","author":"Schon","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2026.106840_bib211","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A","article-title":"How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population","volume":"15","author":"Schrag","year":"2000","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.neubiorev.2026.106840_bib212","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jnnp.73.5.529","article-title":"How valid is the clinical diagnosis of Parkinson's disease in the community?","volume":"73","author":"Schrag","year":"2002","journal-title":"J. Neurol. Neurosurg. & Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106840_bib213","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4103\/1673-5374.270308","article-title":"Leaky gut, dysbiosis, and enteric glia activation: the trilogy behind the intestinal origin of Parkinson\u2019s disease","volume":"15","author":"Seguella","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neubiorev.2026.106840_bib214","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/1871527322666230426155432","article-title":"Neuronal Vulnerability to Degeneration in Parkinson's Disease and Therapeutic Approaches","volume":"23","author":"Sharma","year":"2024","journal-title":"CNS Neurol. Disord. Drug. Targets"},{"key":"10.1016\/j.neubiorev.2026.106840_bib215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052714","article-title":"Neural Crest-Derived Stem Cells (NCSCs) Obtained from Dental-Related Stem Cells (DRSCs): A Literature Review on Current Knowledge and Directions toward Translational Applications","volume":"23","author":"Solis-Castro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib216","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.omtm.2019.03.002","article-title":"AAV5-miHTT gene therapy demonstrates sustained huntingtin lowering and functional improvement in Huntington disease mouse models","volume":"13","author":"Spronck","year":"2019","journal-title":"Mol. Ther. Methods & Clin. Dev."},{"key":"10.1016\/j.neubiorev.2026.106840_bib217","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3390\/brainsci12101308","article-title":"Precision medicine in Parkinson\u2019s disease: from genetic risk signals to personalized therapy","volume":"12","author":"Straccia","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib218","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41420-021-00676-w","article-title":"Phosphorylated alpha-synuclein aggregated in Schwann cells exacerbates peripheral neuroinflammation and nerve dysfunction in Parkinson's disease through TLR2\/NF-kappaB pathway","volume":"7","author":"Sun","year":"2021","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.neubiorev.2026.106840_bib219","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jns.2016.09.061","article-title":"Polyneuropathy in levodopa-treated Parkinson's patients","volume":"371","author":"Szadejko","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.celrep.2019.06.009","article-title":"Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in synucleinopathies","volume":"28","author":"Szeg\u0151","year":"2019","journal-title":"Cell. Rep."},{"key":"10.1016\/j.neubiorev.2026.106840_bib221","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"cell"},{"key":"10.1016\/j.neubiorev.2026.106840_bib222","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0404.1992.tb04043.x","article-title":"Involvement of peripheral nervous system in juvenile Parkinson's disease","volume":"85","author":"Taly","year":"1992","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neubiorev.2026.106840_bib223","first-page":"477","article-title":"Monoamine oxidase-B inhibitors for the treatment of Parkinson\u2019s disease: past, present, and future","volume":"12","author":"Tan","year":"2022","journal-title":"J. Park. \u2019S. Dis."},{"key":"10.1016\/j.neubiorev.2026.106840_bib224","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib225","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-0037-1601888","article-title":"Diagnosis and Management of Parkinson's Disease","volume":"37","author":"Tarakad","year":"2017","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib226","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/geriatrics7020046","article-title":"A narrative review of specialist Parkinson\u2019s nurses: Evolution, evidence and expectation","volume":"7","author":"Tenison","year":"2022","journal-title":"Geriatrics"},{"key":"10.1016\/j.neubiorev.2026.106840_bib227","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnagi.2015.00040","article-title":"Lower limb progressive resistance training improves leg strength but not gait speed or balance in Parkinson's disease: a systematic review and meta-analysis","volume":"7","author":"Tillman","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib228","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib229","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5004","article-title":"Physiotherapy intervention in Parkinson\u2019s disease: systematic review and meta-analysis","volume":"345","author":"Tomlinson","year":"2012","journal-title":"Bmj"},{"key":"10.1016\/j.neubiorev.2026.106840_bib230","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/mds.22137","article-title":"Neuropathy as a potential complication of levodopa use in Parkinson's disease","volume":"23","author":"Toth","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2026.106840_bib231","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.22021","article-title":"Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease","volume":"68","author":"Toth","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib232","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","article-title":"Mitochondrial formation of reactive oxygen species","volume":"552","author":"Turrens","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib233","first-page":"5798","article-title":"Influence of heavy metals in Parkinson\u2019s disease: an overview","volume":"269","author":"Vellingiri","year":"2022"},{"key":"10.1016\/j.neubiorev.2026.106840_bib234","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40035-021-00278-7","article-title":"Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration","volume":"11","author":"Verma","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neubiorev.2026.106840_bib235","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s12035-021-02658-6","article-title":"Neuromuscular junction dysfunction in amyotrophic lateral sclerosis","volume":"59","author":"Verma","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib236","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/CON.0000000000000812","article-title":"Autoimmune autonomic disorders","volume":"26","author":"Vernino","year":"2020","journal-title":"CONTINUUM Lifelong Learn. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib237","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nn1998","article-title":"Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy","volume":"10","author":"Vilchez","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib238","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jns.12099","article-title":"Peripheral neuropathy and parkinsonism: a large clinical and pathogenic spectrum","volume":"19","author":"Vital","year":"2014","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.neubiorev.2026.106840_bib239","doi-asserted-by":"crossref","unstructured":"Wallom K.-L., Fern\u00e1ndez-Su\u00e1rez M.E., Priestman D.A., Te Vruchte D., Huebecker M., Hallett P.J., Isacson O., Platt F.M. (2022), Glycosphingolipid metabolism and its role in ageing and Parkinson\u2019s disease. 39:39-53.","DOI":"10.1007\/s10719-021-10023-x"},{"key":"10.1016\/j.neubiorev.2026.106840_bib240","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40478-023-01552-7","article-title":"Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer\u2019s disease brain","volume":"11","author":"Wang","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neubiorev.2026.106840_bib241","doi-asserted-by":"crossref","DOI":"10.3810\/pgm.2001.12.1063","article-title":"Pain in Parkinson's disease. Common yet seldom recognized symptom is treatable","volume":"110","author":"Waseem","year":"2001","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.neubiorev.2026.106840_bib242","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuropharm.2012.03.004","article-title":"Adeno-associated virus (AAV) gene therapy for neurological disease","volume":"69","author":"Weinberg","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2026.106840_bib243","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51071","article-title":"LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis","volume":"9","author":"Weindel","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.neubiorev.2026.106840_bib244","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1212\/01.wnl.0000275524.15125.f4","article-title":"\u03b1-Synuclein and Parkinson disease susceptibility","volume":"69","author":"Winkler","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2026.106840_bib245","article-title":"Mitochondrial transfer from glia to neurons protects against peripheral neuropathy","author":"Xu","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2026.106840_bib246","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/glia.22491","article-title":"Nerve injury induces glial cell line-derived neurotrophic factor (GDNF) expression in Schwann cells through purinergic signaling and the PKC-PKD pathway","volume":"61","author":"Xu","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.neubiorev.2026.106840_bib247","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jcsm.13123","article-title":"alpha-Synuclein aggregation causes muscle atrophy through neuromuscular junction degeneration","volume":"14","author":"Yang","year":"2023","journal-title":"J. Cachex-.-. Sarcopenia Muscle"},{"key":"10.1016\/j.neubiorev.2026.106840_bib248","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13024-023-00634-3","article-title":"Axonal energy metabolism, and the effects in aging and neurodegenerative diseases","volume":"18","author":"Yang","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2026.106840_bib249","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000527029","article-title":"Effectiveness of Progressive Resistance Training in Parkinson's Disease: A Systematic Review and Meta-Analysis","volume":"86","author":"Yang","year":"2023","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113863","article-title":"PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia\u2013parkinsonism type 14 and can be relieved by DHA treatment in animal models","volume":"346","author":"Yeh","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106840_bib251","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.107103","article-title":"Molecular mechanisms by which mitochondrial dysfunction drives neuromuscular junction degeneration in amyotrophic lateral sclerosis","author":"Yipeng","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2026.106840_bib252","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90503-0","article-title":"Cooperative inhibition of SNARE-mediated vesicle fusion by \u03b1-synuclein monomers and oligomers","volume":"11","author":"Yoo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2026.106840_bib253","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41593-024-01866-2","article-title":"Propagation of pathologic alpha-synuclein from kidney to brain may contribute to Parkinson's disease","volume":"28","author":"Yuan","year":"2025","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib254","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1242\/dmm.028738","article-title":"The role of Ca2+ signaling in Parkinson's disease","volume":"10","author":"Zaichick","year":"2017","journal-title":"Dis. Models & Mech."},{"key":"10.1016\/j.neubiorev.2026.106840_bib255","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopha.2008.01.017","article-title":"Glutathione and Parkinson's disease: is this the elephant in the room?","volume":"62","author":"Zeevalk","year":"2008","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.neubiorev.2026.106840_bib256","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/cns.13282","article-title":"Activated Schwann cells and increased inflammatory cytokines IL-1\u03b2, IL-6, and TNF-\u03b1 in patients' sural nerve are lack of tight relationship with specific sensory disturbances in Parkinson's disease","volume":"26","author":"Zhang","year":"2020","journal-title":"CNS Neurosci. & Ther."},{"key":"10.1016\/j.neubiorev.2026.106840_bib257","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41418-024-01404-4","article-title":"Localized release of muscle-generated BDNF regulates the initial formation of postsynaptic apparatus at neuromuscular synapses","volume":"32","author":"Zhang","year":"2025","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.neubiorev.2026.106840_bib258","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated \u03b1-synuclein activates microglia: a process leading to disease progression in Parkinson's disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.neubiorev.2026.106840_bib259","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12031-011-9560-0","article-title":"Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus","volume":"47","author":"Zhu","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2026.106840_bib260","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jns.2017.05.023","article-title":"Peripheral neuropathy in idiopathic Parkinson's disease: a systematic review","volume":"378","author":"Zis","year":"2017","journal-title":"J. Neurol. Sci."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426002976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426002976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:04:50Z","timestamp":1793977490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763426002976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":260,"alternative-id":["S0149763426002976"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106840","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral nervous system involvement in Parkinson\u2019s disease: Peripheral neuropathy, neuromuscular junction dysfunction, and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106840"}}